🇺🇸 FDA
Pipeline program

ELVN-001

ELVN-001-101

Phase 1 small_molecule active

Quick answer

ELVN-001 for Chronic Myeloid Leukemia is a Phase 1 program (small_molecule) at Enliven Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Enliven Therapeutics
Indication
Chronic Myeloid Leukemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials